Microbiome / Microbiota R&D and Business Collaboration Forum
London, United Kingdom (April, 28 - 29, 2014 )
The flourishing sphere of metagenomics has allowed researchers to delve into the diversity of the body's microbiota with findings that the microbiome is a home for diversity, natural immunity, metabolism, behavioural traits, and plays an instrumental role in health and disease. With large-scale collaborative projects underway and all sequencing data placed in the public domain, there is a rich source of information for researchers and companies looking for opportunities in this exciting field. With an increasing focus on healthy living and a therapeutics market that is expected to grow to $1.2 trillion by 2016, microbial research can be developed in order to provide preventative treatments, cures, therapies and supplements for a worldwide audience in demand.
The forum will build upon our successful American meeting and explore the interface between our evolving cultures, technologies and our microbiome through a series of interactive presentations with leading academics, panel discussions and an exhibition area allowing industry suppliers to showcase their products and services. It will address issues concerning the storage, usage and analysis of the massive amounts of data collected; ethical and regulatory challenges of commercialising research and the latest scientific research into microbial communities - how these affect health, disease and implications for the food world.
The conference will include topics such as:
- The Microbiome Community
- Sequencing and Bioinformatics of the Human Microbiome
- The Human Microbiome in Health and Disease
- New Research in Microbiology Sites
- Microbiome and the Food World
- Venture Capital, Collaboration and Investment
